A Randomized, Double-masked, Study to Evaluate the Efficacy and Safety of OTX-DED (Dexamethasone Intracanalicular Ophthalmic Insert) for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)
Latest Information Update: 19 Jul 2024
At a glance
- Drugs Dexamethasone (Primary)
- Indications Dry eyes
- Focus Adverse reactions
- Sponsors Ocular Therapeutix
Most Recent Events
- 10 Jul 2024 Status changed from active, no longer recruiting to completed.
- 02 Apr 2024 Planned End Date changed from 1 Feb 2024 to 31 May 2024.
- 02 Apr 2024 Planned primary completion date changed from 1 Feb 2024 to 11 Apr 2024.